Abstract

From an O th Th In Publ Fund Conf CLINICAL PRESENTATION We report the case of a 32-year-old male recipient of a life-saving near-full facial transplant performed in May 2013 (Fig 1, A). Induction immunosuppression consisted of anti-thymocyte globulin, tacrolimus, mofetil mycophenolate, and high-dose methylprednisolone. On day 36 posttransplant, confluent erythema with edema of transplanted skin developed (Fig 1, B) and was diagnosed as acute graft rejection, which was successfully treated with methylprednisolone 2 mg/kg body weight tapered after 3 days. No further episodes of graft rejection have been observed (Fig 1, C ).

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call